Bilirubin Elevation During Hospitalization Post Radiofrequency Catheter Ablation of Persistent Atrial Fibrillation: Variation Trend, Related Factors, and Relevance to 1-Year Recurrence

Overview

Journal Clin Interv Aging

Publisher Dove Medical Press

Specialty Geriatrics

Date 2024 May 20

PMID 38765794

Authors

Jia-Meng Shao

Bing Shen

Zhi-Xiang Zhou

Lucia DAngelo

Shea Michaela James

Jia-Feng Lin

Cheng Zheng

Affiliations

Soon will be listed here.

Abstract

Background: The role of total bilirubin (TBIL) in cardiovascular disease has been increasingly recognized in recent decades. Studies have shown a correlation between total bilirubin levels and the prognosis of patients after heart surgery. This study aimed to investigate the clinical significance of bilirubin elevation in persistent atrial fibrillation (PAF) patients who received radiofrequency catheter ablation (RFCA).

Methods And Results: A total of 184 patients with PAF who received RFCA were retrospectively studied. Laboratory examinations and demographic data were analyzed to identify independent predictors of TBIL elevation. The relationship between TBIL and prognosis was further investigated. Our results indicated that TBIL increased significantly after RFCA. Multiple linear regression analysis showed that TBIL elevation owned a negative correlation with the percentile of low voltage areas (LVAs) in left atria (β=-0.490, P<0.001). In contrast, a positive correlation was observed with the white blood cell (WBC) ratio (β=0.153, P=0.042) and left atrial diameter (LAD) (β=0.232, P=0.025). It was found that postoperative TBIL levels increased and then gradually decreased to baseline within 5 days without intervention. The bilirubin ratio <1.211 indicated the possibility of 1-year AF recurrence after ablation with a predictive value of 0.743 (specificity = 75.00%, sensitivity = 66.67%).

Conclusion: Bilirubin elevation post PAF RFCA was a common phenomenon and was associated with 1-year recurrence of AF in PAF patients after RFCA.

References

Xu X, Lv Z, Liu Q, Zhao Q, Wu Y, Sun K . Direct bilirubin: A new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension. Int J Cardiol. 2016; 228:895-899. DOI: 10.1016/j.ijcard.2016.11.036. View

Richter B, Gwechenberger M, Socas A, Zorn G, Albinni S, Marx M . Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation. Clin Res Cardiol. 2011; 101(3):217-25. DOI: 10.1007/s00392-011-0383-3. View

Guzel T, Kis M, Senoz O . The correlation between the left atrial volume index and atrial fibrillation development in heart failure with mildly reduced ejection fraction and long-term follow-up results. Acta Cardiol. 2022; 77(7):647-654. DOI: 10.1080/00015385.2022.2067674. View

Liang Q, Zhang Y, Liang J . Elevated Serum Total Bilirubin Might Indicate Poor Coronary Conditions for Unstable Angina Pectoris Patients beyond as a Cardiovascular Protector. Cardiovasc Ther. 2023; 2023:5532917. PMC: 10497366. DOI: 10.1155/2023/5532917. View

Rubattu S, Forte M, Raffa S . Circulating Leukocytes and Oxidative Stress in Cardiovascular Diseases: A State of the Art. Oxid Med Cell Longev. 2019; 2019:2650429. PMC: 6815586. DOI: 10.1155/2019/2650429. View

Li X, Zhao C, Pan C, Jiang G, Zhang B . Role of bilirubin in the prognosis of coronary artery disease and its relationship with cardiovascular risk factors: a meta-analysis. BMC Cardiovasc Disord. 2022; 22(1):458. PMC: 9632050. DOI: 10.1186/s12872-022-02899-w. View

Lee S, Jee Y, Jung K, Hong S, Shin E, Jee S . Bilirubin and Stroke Risk Using a Mendelian Randomization Design. Stroke. 2017; 48(5):1154-1160. DOI: 10.1161/STROKEAHA.116.015083. View

Shi L, Heng R, Liu S, Leng F . Effect of catheter ablation versus antiarrhythmic drugs on atrial fibrillation: A meta-analysis of randomized controlled trials. Exp Ther Med. 2015; 10(2):816-822. PMC: 4508979. DOI: 10.3892/etm.2015.2545. View

Zhu M, Zhou X, Cai H, Wang Z, Xu H, Chen S . Catheter ablation versus medical rate control for persistent atrial fibrillation in patients with heart failure: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016; 95(30):e4377. PMC: 5265865. DOI: 10.1097/MD.0000000000004377. View

10.

Kundur A, Santhakumar A, Bulmer A, Singh I . Mildly elevated unconjugated bilirubin is associated with reduced platelet activation-related thrombogenesis and inflammation in Gilbert's syndrome. Platelets. 2017; 28(8):779-785. DOI: 10.1080/09537104.2017.1280146. View

11.

Bulmer A, Bakrania B, Du Toit E, Boon A, Clark P, Powell L . Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea. Am J Physiol Heart Circ Physiol. 2018; 315(3):H429-H447. DOI: 10.1152/ajpheart.00417.2017. View

12.

Chen X, Bai M, Zhang W, Sun S, Chen X . The incidence, risk factors, and prognosis of postoperative hyperbilirubinemia after cardiac surgery: a systematic review and meta-analysis. Ann Palliat Med. 2021; 10(7):7247-7257. DOI: 10.21037/apm-21-410. View

13.

Ryter S . Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders. Antioxidants (Basel). 2022; 11(3). PMC: 8944973. DOI: 10.3390/antiox11030555. View

14.

Nilsen D, Myhre P, Solheim S, Tveit S, Kalstad A, Laake K . Total Bilirubin Yields Prognostic Information Following a Myocardial Infarction in the Elderly. Antioxidants (Basel). 2023; 12(6). PMC: 10295173. DOI: 10.3390/antiox12061157. View

15.

Brueckmann M, Wolpert C, Bertsch T, Sueselbeck T, Liebetrau C, Kaden J . Markers of myocardial damage, tissue healing, and inflammation after radiofrequency catheter ablation of atrial tachyarrhythmias. J Cardiovasc Electrophysiol. 2004; 15(6):686-91. DOI: 10.1046/j.1540-8167.2004.03371.x. View

16.

Targher G, Byrne C . Circulating Markers of Liver Function and Cardiovascular Disease Risk. Arterioscler Thromb Vasc Biol. 2015; 35(11):2290-6. DOI: 10.1161/ATVBAHA.115.305235. View

17.

Tsai M, Tarng D . Beyond a Measure of Liver Function-Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients. Int J Mol Sci. 2019; 20(1). PMC: 6337523. DOI: 10.3390/ijms20010117. View

18.

Nishi H, Sakaguchi T, Miyagawa S, Yoshikawa Y, Fukushima S, Saito S . Frequency, risk factors and prognosis of postoperative hyperbilirubinemia after heart valve surgery. Cardiology. 2012; 122(1):12-9. DOI: 10.1159/000338142. View

19.

Fredenburgh L, Merz A, Cheng S . Haeme oxygenase signalling pathway: implications for cardiovascular disease. Eur Heart J. 2015; 36(24):1512-8. PMC: 4475572. DOI: 10.1093/eurheartj/ehv114. View

20.

Kataoka T, Hamasaki S, Inoue K, Yuasa T, Tomita K, Ishida S . Left atrium volume index and pathological features of left atrial appendage as a predictor of failure in postoperative sinus conversion. J Cardiol. 2010; 55(2):274-82. DOI: 10.1016/j.jjcc.2009.11.007. View